Topics

Human medicines European public assessment report (EPAR): EndolucinBeta, lutetium (177 Lu) chloride, Radionuclide Imaging, Date of authorisation: 06/07/2016, Revision: 5, Status: Authorised

10:30 EDT 11 Oct 2019 | European Medicines Agency

Human medicines European public assessment report (EPAR): EndolucinBeta, lutetium (177 Lu) chloride, Radionuclide Imaging, Date of authorisation: 06/07/2016, Revision: 5, Status: Authorised

Original Article: Human medicines European public assessment report (EPAR): EndolucinBeta, lutetium (177 Lu) chloride, Radionuclide Imaging, Date of authorisation: 06/07/2016, Revision: 5, Status: Authorised

NEXT ARTICLE

More From BioPortfolio on "Human medicines European public assessment report (EPAR): EndolucinBeta, lutetium (177 Lu) chloride, Radionuclide Imaging, Date of authorisation: 06/07/2016, Revision: 5, Status: Authorised"

Quick Search